Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Change in Taxes (2016 - 2020)

Historic Change in Taxes for Harvard Bioscience (HBIO) over the last 12 years, with Q3 2020 value amounting to -$241000.0.

  • Harvard Bioscience's Change in Taxes fell 478.26% to -$241000.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $330000.0, marking a year-over-year increase of 27368.42%. This contributed to the annual value of -$363000.0 for FY2019, which is 15931.37% down from last year.
  • As of Q3 2020, Harvard Bioscience's Change in Taxes stood at -$241000.0, which was down 478.26% from $337000.0 recorded in Q2 2020.
  • Over the past 5 years, Harvard Bioscience's Change in Taxes peaked at $555000.0 during Q3 2018, and registered a low of -$741000.0 during Q2 2019.
  • Over the past 5 years, Harvard Bioscience's median Change in Taxes value was $6000.0 (recorded in 2020), while the average stood at $19368.4.
  • As far as peak fluctuations go, Harvard Bioscience's Change in Taxes surged by 57837.84% in 2017, and later crashed by 105740.74% in 2018.
  • Quarter analysis of 5 years shows Harvard Bioscience's Change in Taxes stood at -$37000.0 in 2016, then surged by 578.38% to $177000.0 in 2017, then skyrocketed by 126.55% to $401000.0 in 2018, then crashed by 43.14% to $228000.0 in 2019, then tumbled by 205.7% to -$241000.0 in 2020.
  • Its last three reported values are -$241000.0 in Q3 2020, $337000.0 for Q2 2020, and $6000.0 during Q1 2020.